Skip to main content

Advertisement

SpringerLink
Log in

Imaging techniques in the evaluation and management of hypertrophic cardiomyopathy

  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease, the leading cause of sudden cardiac death in young patients, and an important cause of heart failure symptoms in patients of all ages. This article reviews the role of a number of traditional and advanced imaging techniques that can now be considered in the contemporary evaluation of patients with HCM, with important implications for management strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Marian AJ, Roberts R: Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995, 92:1336–1347.

    PubMed  CAS  Google Scholar 

  2. Maron BJ, Gottdiener JS, Epstein SE: Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 1981, 48:418–428.

    Article  PubMed  CAS  Google Scholar 

  3. Maron BJ, McKenna WJ, Danielson GK, et al.: American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003, 42:1687–1713.

    Article  PubMed  Google Scholar 

  4. Wigle ED, Sasson Z, Henderson MA, et al.: Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 1985, 28:1–83.

    Article  PubMed  CAS  Google Scholar 

  5. Shapiro LM, McKenna WJ: Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a twodimensional echocardiographic study. J Am Coll Cardiol 1983, 2:437–444.

    PubMed  CAS  Google Scholar 

  6. Adelman AG, McLoughlin MJ, Marquis Y, et al.: Left ventricular cineangiographic observations in muscular subaortic stenosis. Am J Cardiol 1969, 24:689–697.

    Article  PubMed  CAS  Google Scholar 

  7. Braunwald E, Lambrew CT, Rockoff SD, et al.: Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation 1964, 30(Suppl 4):3–119.

    Google Scholar 

  8. Maron BJ: Hypertrophic cardiomyopathy: a systematic review. JAMA 2002, 287:1308–1320.

    Article  PubMed  Google Scholar 

  9. Shah PM, Gramiak R, Kramer DH: Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation 1969, 40:3–11.

    PubMed  CAS  Google Scholar 

  10. Klues HG, Roberts WC, Maron BJ: Morphological determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy. Circulation 1993, 87:1570–1579.

    PubMed  CAS  Google Scholar 

  11. Klues HG, Schiffers A, Maron BJ: Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995, 26:1699–1708.

    Article  PubMed  CAS  Google Scholar 

  12. Pollick C, Rakowski H, Wigle ED: Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient. Circulation 1984, 69:43–49.

    PubMed  CAS  Google Scholar 

  13. Wigle ED, Rakowski H, Kimball BP, Williams WG: Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 1995, 92:1680–1692.

    PubMed  CAS  Google Scholar 

  14. Moon JC, Fisher NG, McKenna WJ, Pennell DJ: Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 2004, 90:645–649.

    Article  PubMed  CAS  Google Scholar 

  15. Rickers C, Wilke NM, Jerosch-Herold M, et al.: Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005, 112:855–861.

    Article  PubMed  Google Scholar 

  16. Spirito P, Bellone P, Harris KM, et al.: Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000, 342:1778–1785.

    Article  PubMed  CAS  Google Scholar 

  17. Sorajja P, Nishimura RA, Ommen SR, et al.: Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy. J Am Soc Echocardiogr 2006, 19:788–795.

    Article  PubMed  Google Scholar 

  18. Maron BJ, Seidman JG, Seidman CE: Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 44:2125–2132.

    Article  PubMed  Google Scholar 

  19. Maron MS, Olivotto I, Zenovich AG, et al.: Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 2006, 114:2232–2239.

    Article  PubMed  Google Scholar 

  20. Spirito P, Maron BJ: Patterns of systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: assessment by two-dimensional echocardiography. Am J Cardiol 1984, 54:1039–1046.

    Article  PubMed  CAS  Google Scholar 

  21. Schwammenthal E, Nakatani S, He S, et al.: Mechanism of mitral regurgitation in hypertrophic cardiomyopathy: mismatch of posterior to anterior leaflet length and mobility. Circulation 1998, 98:856–865.

    PubMed  CAS  Google Scholar 

  22. Sherrid MV, Chaudhry FA, Swistel DG: Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thoracic Surg 2003, 75:620–632.

    Article  Google Scholar 

  23. Maron BJ, Gottdiener JS, Arce J, et al.: Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Doppler echocardiography. J Am Coll Cardiol 1985, 6:1–18.

    Article  PubMed  CAS  Google Scholar 

  24. Maron MS, Olivotto I, Betocchi S, et al.: Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003, 348:295–303.

    Article  PubMed  Google Scholar 

  25. Ommen SR, Maron BJ, Olivotto I, et al.: Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005, 46:470–476.

    Article  PubMed  Google Scholar 

  26. Maron BJ, Nishimura RA, Danielson GK: Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle. Circulation 1998, 98:2505–2508.

    PubMed  CAS  Google Scholar 

  27. Yu EH, Omran AS, Wigle ED, et al.: Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol 2000, 36:2219–2225.

    Article  PubMed  CAS  Google Scholar 

  28. Grigg LE, Wigle ED, Williams WG, et al.: Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making. J Am Coll Cardiol 1992, 20:42–52.

    PubMed  CAS  Google Scholar 

  29. Kimmelstiel CD, Maron BJ: Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 2004, 109:452–456.

    Article  PubMed  Google Scholar 

  30. Faber L, Seggewiss H, Gleichmann U: Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation 1998, 98:2415–2421.

    PubMed  CAS  Google Scholar 

  31. Nagueh SF, Lakkis NM, He ZX, et al.: Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1998, 32:225–229.

    Article  PubMed  CAS  Google Scholar 

  32. Seggewiss H, Gleichmann U, Faber L, et al.: Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998, 31:252–258.

    Article  PubMed  CAS  Google Scholar 

  33. Qin JX, Shiota T, Lever HM, et al.: Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001, 38:1994–2000.

    Article  PubMed  CAS  Google Scholar 

  34. Briguori C, Betocchi S, Losi MA, et al.: Noninvasive evaluation of left ventricular diastolic function in hypertrophic cardiomyopathy. Am J Cardiol 1998, 81:180–187.

    Article  PubMed  CAS  Google Scholar 

  35. Nagueh SF, Lakkis NM, Middleton KJ, et al.: Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 1999, 99:254–261.

    PubMed  CAS  Google Scholar 

  36. Geske JB, Sorajja P, Nishimura RA, Ommen SR: Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation 2007, 116:2702–2708.

    Article  PubMed  Google Scholar 

  37. Harris KM, Spirito P, Maron MS, et al.: Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006, 114:216–225.

    Article  PubMed  Google Scholar 

  38. O’Gara PT, Bonow RO, Maron BJ, et al.: Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 1987, 76:1214–1223.

    PubMed  Google Scholar 

  39. Sorajja P, Chareonthaitawee P, Ommen SR, et al.: Prognostic utility of single-photon emission computed tomography in adult patients with hypertrophic cardiomyopathy. Am Heart Journal 2006, 151:426–435.

    Article  Google Scholar 

  40. Cannon RO, Dilsizian V, O’Gara PT, et al.: Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991, 83:1660–1667.

    PubMed  Google Scholar 

  41. Camici P, Chiriatti G, Lorenzoni R, et al.: Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991, 17:879–886.

    PubMed  CAS  Google Scholar 

  42. Basso C, Thiene G, Corrado D, et al.: Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Human Pathol 2000, 31:988–998.

    Article  CAS  Google Scholar 

  43. Cecchi F, Olivotto I, Gistri R, et al.: Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003, 349:1027–1035.

    Article  PubMed  CAS  Google Scholar 

  44. Olivotto I, Cecchi F, Gistri R, et al.: Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006, 47:1043–1048.

    Article  PubMed  Google Scholar 

  45. Lima JA, Desai MY: Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol 2004, 44:1164–1171.

    Article  PubMed  Google Scholar 

  46. Moon JC, Reed E, Sheppard MN, et al.: The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 43:2260–2264.

    Article  PubMed  Google Scholar 

  47. Maron MS, Buros J, Gibson CM, et al.: Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circulation 2008, 1:184–191.

    PubMed  Google Scholar 

  48. Olivotto I, Maron MS, Autore C, et al.: Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2008, 52:559–566.

    Article  PubMed  Google Scholar 

  49. Choudhury L, Mahrholdt H, Wagner A, et al.: Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002, 40:2156–2164.

    Article  PubMed  Google Scholar 

  50. Adabag AS, Maron BJ, Appelbaum E, et al.: Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008, 51:1369–1374.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Tufts Medical Center, 800 Washington Street, Boston, MA, 02111, USA

    Martin S. Maron

Authors
  1. Alyson Kelley-Hedgepeth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin S. Maron
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin S. Maron.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kelley-Hedgepeth, A., Maron, M.S. Imaging techniques in the evaluation and management of hypertrophic cardiomyopathy. Curr Heart Fail Rep 6, 135–141 (2009). https://doi.org/10.1007/s11897-009-0020-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-009-0020-x

Keywords

Search

Navigation